Goat F(ab')2 Anti-Human IgG H&L (PE) preadsorbed
Goat F(ab')2 Anti-Human IgG H&L (PE) preadsorbed
Be the first to review this product! Submit a review
|
(6 Publications)
Suitable for Flow Cyt, IM, IHC-Fr, IHC-P, ICC/IF, Dot. Preadsorbed to minimise non-specific binding and high background staining. Cited in 6 publications.
別名を表示する
Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1
- Dot
Supplier Data
Dot Blot - Goat F(ab')2 Anti-Human IgG H&L (PE) preadsorbed (AB7006)
Dot blot analysis of ab7006. Imaged with BioRad ChemiDoc, Rhodamine filter.
All lanes:
Dot Blot - Goat F(ab')2 Anti-Human IgG H&L (PE) preadsorbed (ab7006)
Lane 1:
Human IgG at 100 ng
Lane 2:
Human IgG at 33.3 ng
Lane 3:
Human IgG at 11.1 ng
Lane 4:
Human IgG at 3.7 ng
Lane 5:
Human IgG at 1.23 ng
Secondary
All lanes:
Goat F(ab')2 Anti-Human IgG Antibody RPE at 1 µg/mL
false
Reactivity data
製品の詳細
出荷温度及び保存条件
製品の状態
精製方法
精製に関する特記事項
バッファー組成
出荷温度
短期保存温度
長期保存温度
ターゲットの情報
追加のターゲット
文献 (6)
Recent publications for all applications. Explore the full list and refine your search
JCI insight 8: PubMed37606046
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cells 9: PubMed32059493
2020
Applications
Unspecified application
Species
Unspecified reactive species
Current protocols in stem cell biology 44:2A.11.1-2A.11.13 PubMed29512129
2018
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 6:28643 PubMed27345490
2016
Applications
Unspecified application
Species
Unspecified reactive species
Current protocols in stem cell biology 36:1C.15.1-1C.15.16 PubMed26840223
2016
Applications
Unspecified application
Species
Unspecified reactive species
Current protocols in stem cell biology 28:Unit 1C.15. PubMed24510768
2014
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com